Please login to the form below

Not currently logged in
Email:
Password:

tobramycin

This page shows the latest tobramycin news and features for those working in and with pharma, biotech and healthcare.

Sandoz admits antitrust crime, pays $195m in penalties

Sandoz admits antitrust crime, pays $195m in penalties

nystatin/triamcinolone and tobramycin inhalation solution.

Latest news

  • CURx buys rights to Gilead’s lung infection drug CURx buys rights to Gilead’s lung infection drug

    Agrees deal for fosfomycin/tobramycin combination. CURx Pharmaceuticals has acquired the rights to Gilead Sciences' investigational drug for a lung infection associated with cystic fibrosis. ... Dinu Sen, CEO and founder of CURx, said that

  • NICE backs Novartis/ ThromboGenics’ eye drug NICE backs Novartis/ ThromboGenics’ eye drug

    ranibizumab). Novartis has also won the cost-effectiveness watchdog's backing in 2013 for the Tobi Podhaler (tobramycin), a treatment for cystic fibrosis.

  • NICE gives final ‘yes’ to cystic fibrosis drugs from Novartis and Forest NICE gives final ‘yes’ to cystic fibrosis drugs from Novartis and Forest

    Both the Tobi Podhaler (tobramycin) from Novartis and Colobreathe (colistimethate sodium) received backing to treat people with cystic fibrosis who have chronic pulmonary infection caused by Pseudomonas aeruginosa in final guidance ... form. The Tobi

  • NICE backs two cystic fibrosis treatments for NHS use NICE backs two cystic fibrosis treatments for NHS use

    Novartis' Tobi Podhaler is a dry powder version of tobramycin, which is also already available in a nebulised form that is recommended for patients unable to take nebulised colistimethate sodium as ... The recommendation is also limited, however, and the

  • Breathing easier

    Silenor (Somaxon Pharmaceuticals). Sleep maintenance insomnia. US. Tobramycin/dexamethasone. TobraDex ST (Alcon).

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mind+Matter

We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....